Acute cardiovascular hospitalizations and illness severity before and during the COVID-19 pandemic

Vishal N Rao1,2, Michelle D Kelsey1,2, Anita M Kelsey1

  • 1Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA.

Clinical Cardiology
|March 8, 2021
PubMed

Insights

During COVID-19, shelter-in-place orders reduced cardiovascular disease (CVD) hospitalizations, especially heart failure (HF). While HF severity showed minor changes, in-hospital mortality remained stable, indicating no significant increase in risk for acute CVD events.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Global decline in cardiovascular disease (CVD) hospitalizations observed during the COVID-19 pandemic.
  • Uncertainty regarding the specific impact of shelter-in-place orders on acute CVD hospitalizations, illness severity, and patient outcomes.

Purpose of the Study:

  • To investigate the association between COVID-19 shelter-in-place orders and acute CVD hospitalizations (heart failure [HF], acute coronary syndrome [ACS], stroke [CVA]).
  • To assess changes in HF illness severity and in-hospital mortality following the implementation of shelter-in-place mandates.

Main Methods:

  • Comparative analysis of acute CVD hospitalizations at Duke University Health System before and after North Carolina's shelter-in-place order (March 30, 2020).
  • Utilized parallel 2019 cohorts for comparison.
  • Assessed HF illness severity using ADHERE and GWTG-HF risk scores and echocardiography parameters.

Main Results:

  • A decrease in mean daily CVD hospitalizations (18.2 to 16.1) and length of stay was observed post-shelter-in-place, with no significant change in in-hospital mortality.
  • HF hospitalizations decreased (9.0 to 7.7 per day), with a higher proportion of high-risk ADHERE scores (2.5% to 4.5%) but unchanged GWTG-HF risk.
  • Echocardiography revealed lower mean left ventricular ejection fraction (LVEF) and higher mean left ventricular (LV) mass.

Conclusions:

  • The COVID-19 shelter-in-place order correlated with reduced acute CVD hospitalizations, particularly for HF.
  • No significant increase in in-hospital mortality was detected.
  • Minor differences in HF illness severity and echocardiographic measures were noted, suggesting a complex impact of the pandemic on cardiovascular care.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
139
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.4K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
581
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
89
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
141
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
121